How has Stephen Stamp's remuneration changed compared to Biodexa Pharmaceuticals's earnings?
Date
Total Compensation
Salary
Company Earnings
Jun 30 2022
n/a
n/a
-UK£5m
Mar 31 2022
n/a
n/a
-UK£5m
Dec 31 2021
UK£329k
UK£187k
-UK£5m
Sep 30 2021
n/a
n/a
-UK£7m
Jun 30 2021
n/a
n/a
-UK£8m
Mar 31 2021
n/a
n/a
-UK£15m
Dec 31 2020
UK£193k
UK£175k
-UK£22m
Jun 30 2020
n/a
n/a
-UK£22m
Mar 31 2020
n/a
n/a
-UK£16m
Dec 31 2019
UK£207k
UK£50k
-UK£9m
Compensation vs Market: Stephen's total compensation ($USD296.50K) is about average for companies of similar size in the UK market ($USD349.05K).
Compensation vs Earnings: Stephen's compensation has been consistent with company performance over the past year.
CEO
Stephen Stamp (60 yo)
3.6yrs
Tenure
UK£237,897
Compensation
Mr. Stephen A. Stamp serves as Chief Financial Officer and Director of Biodexa Pharmaceuticals Plc (formerly known as Midatech Pharma plc) since September 9, 2019. He serves as Chief Executive Officer at B...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Stephen Stamp
CEO, CFO
3.6yrs
UK£237.90k
0.0026% £ 93.7
Dmitry Zamoryakhin
Chief Scientific Officer
1.8yrs
UK£236.68k
no data
Daniel Palmer
Vice President of Technology
2.3yrs
no data
no data
Vincent Holmes
VP & Head of Clinical Operations
less than a year
no data
no data
David Benharris
President of Midatech Pharma US Inc
7.3yrs
no data
no data
Fiona Sharp
Group Financial Controller
no data
no data
no data
2.3yrs
Average Tenure
57yo
Average Age
Experienced Management: BDRX's management team is considered experienced (2.3 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Stephen Stamp
CEO, CFO
3.6yrs
UK£237.90k
0.0026% £ 93.7
Simon Turton
Senior Independent Non-Executive Director
8.3yrs
UK£31.54k
0.0029% £ 103.6
Stephen Parker
Non-Executive Chairman
less than a year
UK£43.84k
no data
Daniel McCurdy
Member of Scientific Advisory Board
no data
no data
no data
Sijmen de Vries
Independent Non-Executive Director
18.5yrs
UK£31.54k
0.0012% £ 44.0
Michael Natan
Member of Scientific Advisory Board
no data
no data
no data
Francesco Stellaci
Chairman of Scientific Advisory Board
no data
no data
no data
David Male
Member of Scientific Advisory Board
no data
no data
no data
Lorraine O'Driscoll
Member of Scientific Advisory Board
no data
no data
no data
Soledad Penades
Member of Scientific Advisory Board
no data
no data
no data
Jean-Christophe Roux
Member of Scientific Advisory Board
no data
no data
no data
Silke Krol
Member of Scientific Advisory Board
no data
no data
no data
6.0yrs
Average Tenure
63yo
Average Age
Experienced Board: BDRX's board of directors are considered experienced (6 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/04/27 01:51
End of Day Share Price
2023/04/25 00:00
Earnings
2022/06/30
Annual Earnings
2021/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biodexa Pharmaceuticals Plc is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.